NEWS
News Updates
Information Center
2020-09-29
To implement the《Drug Administration Law》and the《Traditional Chinese Medicine Law》and to support the enforcement of the《Measures for Drug Registration Management》(Order No. 27 of the State Administration for Market Regulation), the National Medical Products Administration has organized the development of the《Classification of Traditional Chinese Medicine Registration and Requirements for Submission of Application Materials》, which is hereby released.
The new Drug Registration Management Measures will come into effect on July 1, 2020.
2020-03-30
The “Administrative Measures for Drug Registration” were reviewed and approved at the 1st Bureau Meeting of the State Administration for Market Regulation in 2020 on January 15, 2020. They are now promulgated and shall take effect as of July 1, 2020.
The new version of GCP will take effect starting July 1, 2020.
2020-09-25
Good Clinical Practice for Drug Clinical Trials
Guiding Principles for the Data Monitoring Committee of Clinical Drug Trials (Trial Implementation)
2020-09-25
Guiding Principles for the Data Monitoring Committee of Clinical Drug Trials (Trial Implementation)
Uniting Hearts and Combining Forces: Otaikang’s Internal Training Successfully Held
2020-09-25
From June 2 to 3, 2018, the Aotekang Group held an internal training session in Beijing, themed “Unite Hearts and Pool Strengths to Secure a Winning Future.”
2020-09-24
On April 5, 2019, the kickoff meeting for the Phase I clinical trial of a Class 1.1 new chemical drug project, a well-known listed company's drug, was held. Eurasia Huizhi (Beijing) Medical Research Co., Ltd. served as the contract research organization for this project.
Leave a message for inquiry